360 related articles for article (PubMed ID: 27188282)
1. Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition.
Davis MR; Daggett JJ; Pascual AS; Lam JM; Leyva KJ; Cooper KE; Hull EE
BMC Cancer; 2016 May; 16():316. PubMed ID: 27188282
[TBL] [Abstract][Full Text] [Related]
2. SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level.
Yamamichi-Nishina M; Ito T; Mizutani T; Yamamichi N; Watanabe H; Iba H
J Biol Chem; 2003 Feb; 278(9):7422-30. PubMed ID: 12493776
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the glycome after HDAC inhibition impact oncogenic potential in epigenetically plastic SW13 cells.
Montgomery MR; Hull EE
BMC Cancer; 2019 Jan; 19(1):79. PubMed ID: 30651077
[TBL] [Abstract][Full Text] [Related]
4. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of BRM/SMARCA2 sensitizes clear cell renal cell carcinoma to histone deacetylase complex inhibitors.
Fang R; Pan R; Wang X; Liang Y; Wang X; Ma H; Zhou X; Xia Q; Rao Q
Pathol Res Pract; 2020 Apr; 216(4):152867. PubMed ID: 32067803
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of integrated proviral gene expression requires Brm, a catalytic subunit of SWI/SNF complex.
Mizutani T; Ito T; Nishina M; Yamamichi N; Watanabe A; Iba H
J Biol Chem; 2002 May; 277(18):15859-64. PubMed ID: 11850427
[TBL] [Abstract][Full Text] [Related]
7. The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential.
Yamamichi N; Yamamichi-Nishina M; Mizutani T; Watanabe H; Minoguchi S; Kobayashi N; Kimura S; Ito T; Yahagi N; Ichinose M; Omata M; Iba H
Oncogene; 2005 Aug; 24(35):5471-81. PubMed ID: 16007216
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Brahma expression by the mitogen-activated protein kinase/extracellular signal regulated kinase pathway is associated with changes in melanoma proliferation.
Mehrotra A; Saladi SV; Trivedi AR; Aras S; Qi H; Jayanthy A; Setaluri V; de la Serna IL
Arch Biochem Biophys; 2014 Dec; 563():125-35. PubMed ID: 25026375
[TBL] [Abstract][Full Text] [Related]
10. EP300-HDAC1-SWI/SNF functional unit defines transcription of some DNA repair enzymes during differentiation of human macrophages.
Pietrzak J; Płoszaj T; Pułaski Ł; Robaszkiewicz A
Biochim Biophys Acta Gene Regul Mech; 2019 Feb; 1862(2):198-208. PubMed ID: 30414852
[TBL] [Abstract][Full Text] [Related]
11. Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.
Sinha S; Verma S; Chaturvedi MM
DNA Cell Biol; 2016 Aug; 35(8):373-84. PubMed ID: 27097303
[TBL] [Abstract][Full Text] [Related]
12. BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.
Wu S; Ge Y; Huang L; Liu H; Xue Y; Zhao Y
Cell Cycle; 2014; 13(18):2869-78. PubMed ID: 25486475
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation.
Bourachot B; Yaniv M; Muchardt C
EMBO J; 2003 Dec; 22(24):6505-15. PubMed ID: 14657023
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and characterization of α, β-unsaturated carboxylic acid, and its urea based derivatives that explores novel epigenetic modulators in human non-small cell lung cancer A549 cell line.
Chidambaram A; Sundararaju K; Chidambaram RK; Subbiah R; Jayaraj JM; Muthusamy K; Vilwanathan R
J Cell Physiol; 2018 Jul; 233(7):5293-5309. PubMed ID: 29215703
[TBL] [Abstract][Full Text] [Related]
15. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
[TBL] [Abstract][Full Text] [Related]
16. HD2C histone deacetylase and a SWI/SNF chromatin remodelling complex interact and both are involved in mediating the heat stress response in Arabidopsis.
Buszewicz D; Archacki R; Palusiński A; Kotliński M; Fogtman A; Iwanicka-Nowicka R; Sosnowska K; Kuciński J; Pupel P; Olędzki J; Dadlez M; Misicka A; Jerzmanowski A; Koblowska MK
Plant Cell Environ; 2016 Oct; 39(10):2108-22. PubMed ID: 27083783
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
18. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
19. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state.
Yamamichi N; Inada K; Ichinose M; Yamamichi-Nishina M; Mizutani T; Watanabe H; Shiogama K; Fujishiro M; Okazaki T; Yahagi N; Haraguchi T; Fujita S; Tsutsumi Y; Omata M; Iba H
Cancer Res; 2007 Nov; 67(22):10727-35. PubMed ID: 18006815
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone deacetylases.
Huang Y; Shaw PG; Davidson NE
Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
